Medical Billing Code Search
What is a code?
9172 results found
| V5243 | Hearing aid, monaural, itc | Description: Hearing aid, analog, monaural, itc (in the canal) |
| V5244 | Hearing aid, prog, mon, cic | Description: Hearing aid, digitally programmable analog, monaural, cic |
| V5245 | Hearing aid, prog, mon, itc | Description: Hearing aid, digitally programmable, analog, monaural, itc |
| V5246 | Hearing aid, prog, mon, ite | Description: Hearing aid, digitally programmable analog, monaural, ite (in the ear) |
| V5247 | Hearing aid, prog, mon, bte | Description: Hearing aid, digitally programmable analog, monaural, bte (behind the ear) |
| V5248 | Hearing aid, binaural, cic | Description: Hearing aid, analog, binaural, cic |
| V5249 | Hearing aid, binaural, itc | Description: Hearing aid, analog, binaural, itc |
| V5250 | Hearing aid, prog, bin, cic | Description: Hearing aid, digitally programmable analog, binaural, cic |
| V5251 | Hearing aid, prog, bin, itc | Description: Hearing aid, digitally programmable analog, binaural, itc |
| V5252 | Hearing aid, prog, bin, ite | Description: Hearing aid, digitally programmable, binaural, ite |
| V5253 | Hearing aid, prog, bin, bte | Description: Hearing aid, digitally programmable, binaural, bte |
| V5254 | Hearing id, digit, mon, cic | Description: Hearing aid, digital, monaural, cic |
| V5255 | Hearing aid, digit, mon, itc | Description: Hearing aid, digital, monaural, itc |
| V5256 | Hearing aid, digit, mon, ite | Description: Hearing aid, digital, monaural, ite |
| V5257 | Hearing aid, digit, mon, bte | Description: Hearing aid, digital, monaural, bte |
| V5258 | Hearing aid, digit, bin, cic | Description: Hearing aid, digital, binaural, cic |
| V5259 | Hearing aid, digit, bin, itc | Description: Hearing aid, digital, binaural, itc |
| V5260 | Hearing aid, digit, bin, ite | Description: Hearing aid, digital, binaural, ite |
| V5261 | Hearing aid, digit, bin, bte | Description: Hearing aid, digital, binaural, bte |
| V5262 | Hearing aid, disp, monaural | Description: Hearing aid, disposable, any type, monaural |
| V5263 | Hearing aid, disp, binaural | Description: Hearing aid, disposable, any type, binaural |
| V5264 | Ear mold/insert | Description: Ear mold/insert, not disposable, any type |
| V5265 | Ear mold/insert, disp | Description: Ear mold/insert, disposable, any type |
| V5266 | Battery for hearing device | Description: Battery for use in hearing device |
| V5267 | Hearing aid sup/access/dev | Description: Hearing aid or assistive listening device/supplies/accessories, not otherwise specified |
| V5268 | Ald telephone amplifier | Description: Assistive listening device, telephone amplifier, any type |
| V5269 | Alerting device, any type | Description: Assistive listening device, alerting, any type |
| V5270 | Ald, tv amplifier, any type | Description: Assistive listening device, television amplifier, any type |
| V5271 | Ald, tv caption decoder | Description: Assistive listening device, television caption decoder |
| V5272 | Tdd | Description: Assistive listening device, tdd |
| V5273 | Ald for cochlear implant | Description: Assistive listening device, for use with cochlear implant |
| V5274 | Ald unspecified | Description: Assistive listening device, not otherwise specified |
| V5275 | Ear impression | Description: Ear impression, each |
| V5281 | Ald fm/dm system, monaural | Description: Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type |
| V5282 | Ald fm/dm system binaural | Description: Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type |
| V5283 | Ald neck, loop ind receiver | Description: Assistive listening device, personal fm/dm neck, loop induction receiver |
| V5284 | Ald fm/dm ear level receiver | Description: Assistive listening device, personal fm/dm, ear level receiver |
| V5285 | Ald fm/dm aud input receiver | Description: Assistive listening device, personal fm/dm, direct audio input receiver |
| V5286 | Ald blu tooth fm/dm receiver | Description: Assistive listening device, personal blue tooth fm/dm receiver |
| V5287 | Ald fm/dm receiver, nos | Description: Assistive listening device, personal fm/dm receiver, not otherwise specified |
| V5288 | Ald fm/dm transmitter ald | Description: Assistive listening device, personal fm/dm transmitter assistive listening device |
| V5289 | Ald fm/dm adapt/boot couplin | Description: Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type |
| V5290 | Ald transmitter microphone | Description: Assistive listening device, transmitter microphone, any type |
| V5298 | Hearing aid noc | Description: Hearing aid, not otherwise classified |
| V5299 | Hearing service | Description: Hearing service, miscellaneous |
| V5336 | Repair communication device | Description: Repair/modification of augmentative communicative system or device (excludes adaptive hearing aid) |
| V5362 | Speech screening | Description: Speech screening |
| V5363 | Language screening | Description: Language screening |
| V5364 | Dysphagia screening | Description: Dysphagia screening |
| C9088 | Instill, bupivac and meloxic | Description: Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg |
| C9174 | Datopotamab deruxtecan, 1 mg | Description: Injection, datopotamab deruxtecan-dlnk, 1 mg |
| C9175 | Inj, treosulfan, 50 mg | Description: Injection, treosulfan, 50 mg |
| C9248 | Inj, clevidipine butyrate | Description: Injection, clevidipine butyrate, 1 mg |
| E0716 | Supp and acces intravag pelv | Description: Supplies and accessories for intravaginal device intended to strengthen pelvic floor muscles during kegel exercises |
| J2150 | Mannitol injection | Description: Injection, mannitol, 25% in 50 ml |
| J2503 | Pegaptanib sodium injection | Description: Injection, pegaptanib sodium, 0.3 mg |
| S0074 | Injection, cefotetan disodiu | Description: Injection, cefotetan disodium, 500 mg |
| C5271 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area |
| C5272 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure) |
| C5273 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children |
| C5274 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure) |
| C5275 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area |
| C5276 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure) |
| C5277 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children |
| C5278 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure) |
| C9089 | Bupivacaine implant, 1 mg | Description: Bupivacaine, collagen-matrix implant, 1 mg |
| C9305 | Inj, nipocalimab-aahu, 3 mg | Description: Injection, nipocalimab-aahu, 3 mg |
| C9306 | Telisotuzumab vedotin-tllv | Description: Injection, telisotuzumab vedotin-tllv, 1 mg |
| C9751 | Microwave bronch, 3d, ebus | Description: Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s) |
| C9784 | Endo sleeve gastro w/tube | Description: Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components |
| G0071 | Comm svcs by rhc/fqhc 5 min | Description: Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
| G0511 | Ccm/bhi by rhc/fqhc 20min mo | Description: Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
| G0512 | Cocm by rhc/fqhc 60 min mo | Description: Rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month |
| G6001 | Echo guidance radiotherapy | Description: Ultrasonic guidance for placement of radiation therapy fields |
| G6002 | Stereoscopic x-ray guidance | Description: Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy |
| G6003 | Radiation treatment delivery | Description: Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev |
| G6004 | Radiation treatment delivery | Description: Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev |
| G6005 | Radiation treatment delivery | Description: Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev |
| G6006 | Radiation treatment delivery | Description: Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater |
| G6007 | Radiation treatment delivery | Description: Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev |
| G6008 | Radiation treatment delivery | Description: Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev |
| G6009 | Radiation treatment delivery | Description: Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev |
| G6010 | Radiation treatment delivery | Description: Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater |
| G6011 | Radiation treatment delivery | Description: Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev |
| G6012 | Radiation treatment delivery | Description: Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev |
| G6013 | Radiation treatment delivery | Description: Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev |
| G6014 | Radiation treatment delivery | Description: Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater |
| G6015 | Radiation tx delivery imrt | Description: Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
| G6016 | Delivery comp imrt | Description: Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session |
| G6017 | Intrafraction track motion | Description: Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment |
| G9604 | Pt surv results not avail | Description: Patient survey results not available |
| J0172 | Inj, aducanumab-avwa, 2 mg | Description: Injection, aducanumab-avwa, 2 mg |
| J0190 | Inj biperiden lactate/5 mg | Description: Injection, biperiden lactate, per 5 mg |
| J0200 | Alatrofloxacin mesylate | Description: Injection, alatrofloxacin mesylate, 100 mg |
| J0205 | Alglucerase injection | Description: Injection, alglucerase, per 10 units |
| J0215 | Alefacept | Description: Injection, alefacept, 0.5 mg |
| J0288 | Ampho b cholesteryl sulfate | Description: Injection, amphotericin b cholesteryl sulfate complex, 10 mg |
| J0350 | Injection anistreplase 30 u | Description: Injection, anistreplase, per 30 units |
| J0365 | Aprotonin, 10,000 kiu | Description: Injection, aprotonin, 10,000 kiu |
| J0380 | Inj metaraminol bitartrate | Description: Injection, metaraminol bitartrate, per 10 mg |
| J0395 | Arbutamine hcl injection | Description: Injection, arbutamine hcl, 1 mg |
| J0710 | Cephapirin sodium injection | Description: Injection, cephapirin sodium, up to 1 gm |
| J0715 | Ceftizoxime sodium / 500 mg | Description: Injection, ceftizoxime sodium, per 500 mg |
| J0795 | Corticorelin ovine triflutal | Description: Injection, corticorelin ovine triflutate, 1 microgram |
| J0889 | Daprodustat oral 1mg esrd | Description: Daprodustat, oral, 1 mg, (for esrd on dialysis) |
| J1267 | Doripenem injection | Description: Injection, doripenem, 10 mg |
| J1330 | Ergonovine maleate injection | Description: Injection, ergonovine maleate, up to 0.2 mg |
| J1443 | Inj ferric pyrophosphate cit | Description: Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron |
| J1444 | Fe pyro cit pow 0.1 mg iron | Description: Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron |
| J1445 | Inj triferic avnu 0.1mg iron | Description: Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron |
| J1452 | Intraocular fomivirsen na | Description: Injection, fomivirsen sodium, intraocular, 1.65 mg |
| J1457 | Gallium nitrate injection | Description: Injection, gallium nitrate, 1 mg |
| J1562 | Vivaglobin, inj | Description: Injection, immune globulin (vivaglobin), 100 mg |
| J1572 | Flebogamma injection | Description: Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg |
| J1620 | Gonadorelin hydroch/ 100 mcg | Description: Injection, gonadorelin hydrochloride, per 100 mcg |
| J1655 | Tinzaparin sodium injection | Description: Injection, tinzaparin sodium, 1000 iu |
| J1710 | Hydrocortisone sodium ph inj | Description: Injection, hydrocortisone sodium phosphate, up to 50 mg |
| J1945 | Lepirudin | Description: Injection, lepirudin, 50 mg |
| J2504 | Pegademase bovine, 25 iu | Description: Injection, pegademase bovine, 25 iu |
| J2513 | Pentastarch 10% solution | Description: Injection, pentastarch, 10% solution, 100 ml |
| J2910 | Aurothioglucose injeciton | Description: Injection, aurothioglucose, up to 50 mg |
| J2940 | Somatrem injection | Description: Injection, somatrem, 1 mg |
| J2995 | Inj streptokinase /250000 iu | Description: Injection, streptokinase, per 250,000 iu |
| J3280 | Thiethylperazine maleate inj | Description: Injection, thiethylperazine maleate, up to 10 mg |
| J3305 | Inj trimetrexate glucoronate | Description: Injection, trimetrexate glucuronate, per 25 mg |
| J3310 | Perphenazine injeciton | Description: Injection, perphenazine, up to 5 mg |
| J3320 | Spectinomycn di-hcl inj | Description: Injection, spectinomycin dihydrochloride, up to 2 gm |
| J3355 | Urofollitropin, 75 iu | Description: Injection, urofollitropin, 75 iu |
| J3364 | Urokinase 5000 iu injection | Description: Injection, urokinase, 5000 iu vial |
| J3365 | Urokinase 250,000 iu inj | Description: Injection, iv, urokinase, 250,000 i.u. vial |
| J3400 | Triflupromazine hcl inj | Description: Injection, triflupromazine hcl, up to 20 mg |
| J7309 | Methyl aminolevulinate, top | Description: Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram |
| J7310 | Ganciclovir long act implant | Description: Ganciclovir, 4.5 mg, long-acting implant |
| J7505 | Monoclonal antibodies | Description: Muromonab-cd3, parenteral, 5 mg |
| J7513 | Daclizumab, parenteral | Description: Daclizumab, parenteral, 25 mg |
| J8562 | Oral fludarabine phosphate | Description: Fludarabine phosphate, oral, 10 mg |
| J8650 | Nabilone oral | Description: Nabilone, oral, 1 mg |
| J9019 | Erwinaze injection | Description: Injection, asparaginase (erwinaze), 1,000 iu |
| J9020 | Asparaginase, nos | Description: Injection, asparaginase, not otherwise specified, 10,000 units |
| J9098 | Cytarabine liposome inj | Description: Injection, cytarabine liposome, 10 mg |
| J9151 | Daunorubicin citrate inj | Description: Injection, daunorubicin citrate, liposomal formulation, 10 mg |
| J9165 | Diethylstilbestrol injection | Description: Injection, diethylstilbestrol diphosphate, 250 mg |
| J9212 | Interferon alfacon-1 inj | Description: Injection, interferon alfacon-1, recombinant, 1 microgram |
| J9270 | Plicamycin (mithramycin) inj | Description: Injection, plicamycin, 2.5 mg |
| Q0174 | Thiethylperazine maleate10mg | Description: Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q2017 | Teniposide, 50 mg | Description: Injection, teniposide, 50 mg |
| Q4100 | Skin substitute, nos | Description: Skin substitute, not otherwise specified |
| Q4106 | Dermagraft | Description: Dermagraft, per square centimeter |
| Q5109 | Injection, ixifi, 10 mg | Description: Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg |
| Q9969 | Non-heu tc-99m add-on/dose | Description: Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
| S0013 | Esketamine, nasal spray | Description: Esketamine, nasal spray, 1 mg |
| S0080 | Injection, pentamidine iseth | Description: Injection, pentamidine isethionate, 300 mg |
| A2001 | Innovamatrix ac, per sq cm | Description: Innovamatrix ac, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2002 | Mirragen adv wnd mat per sq | Description: Mirragen advanced wound matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2005 | Microlyte matrix, per sq cm | Description: Microlyte matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2006 | Novosorb synpath per sq cm | Description: Novosorb synpath dermal matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2007 | Restrata, per sq cm | Description: Restrata, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2008 | Theragenesis, per sq cm | Description: Theragenesis, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2009 | Symphony, per sq cm | Description: Symphony, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2010 | Apis, per square centimeter | Description: Apis, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2011 | Supra sdrm, per sq cm | Description: Supra sdrm, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2012 | Suprathel, per sq cm | Description: Suprathel, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2013 | Innovamatrix fs, per sq cm | Description: Innovamatrix fs, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2015 | Phoenix wnd mtrx, per sq cm | Description: Phoenix wound matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2016 | Permeaderm b, per sq cm | Description: Permeaderm b, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2018 | Permeaderm c, per sq cm | Description: Permeaderm c, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2019 | Kerecis marigen shld sq cm | Description: Kerecis omega3 marigen shield, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2021 | Neomatrix per sq cm | Description: Neomatrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2022 | Innovabrn/innovamatx xl sqcm | Description: Innovaburn or innovamatrix xl, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2024 | Resolve or xenopatch sq cm | Description: Resolve matrix or xenopatch, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2025 | Miro3d per cubic cm | Description: Miro3d, per cubic centimeter (add-on, list separately in addition to primary procedure) |
| A2027 | Matriderm per sq cm | Description: Matriderm, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2029 | Mirotract matrix sheet | Description: Mirotract wound matrix sheet, per cubic centimeter (add-on, list separately in addition to primary procedure) |
| A2031 | Mirodry, per sq cm | Description: Mirodry wound matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2032 | Myriad matrix, per sq cm | Description: Myriad matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2034 | Found drs solo, per sq cm | Description: Foundation drs solo, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2036 | Cohealyx col dml mx pr sq cm | Description: Cohealyx collagen dermal matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2038 | Marigen pacto, per sq cm | Description: Marigen pacto, per square centimeter (add-on, list separately in addition to primary procedure) |
| A2039 | Innovamatrix fd, per sq cm | Description: Innovamatrix fd, per square centimeter (add-on, list separately in addition to primary procedure) |
| A4100 | Nosht skin sub fda clrd nos | Description: Non-sheet form skin substitute, fda cleared as a device, not otherwise specified (list in addition to primary procedure) |
| A4295 | Straigh tip hydrophilic cath | Description: Intermittent urinary catheter; straight tip, hydrophilic coating, each |
| A4296 | Coude tip hydrophilic cath | Description: Intermittent urinary catheter; coude (curved) tip, hydrophilic coating, each |
| A4297 | Hydrophilic coat insert sup | Description: Intermittent urinary catheter; hydrophilic coating, with insertion supplies |
| A4351 | Straight tip urine catheter | Description: Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each |
| A4352 | Coude tip urinary catheter | Description: Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, or silicone elastomeric, etc.), each |
| A9507 | In111 capromab | Description: Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries |
| A9508 | I131 iodobenguate, dx | Description: Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie |
| A9532 | I125 serum albumin, dx | Description: Iodine i-125 serum albumin, diagnostic, per 5 microcuries |
| A9553 | Cr51 chromate | Description: Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries |
| A9554 | I125 iothalamate, dx | Description: Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries |
| C1607 | Neurostim integ rechg | Description: Neurostimulator, integrated (implantable), rechargeable with all implantable and external components including charging system |
| C1608 | Prosthesis, dual mob cmc1 | Description: Prosthesis, total, dual mobility, first carpometacarpal joint (implantable) |
| C1741 | Anchor/screw bone absorb | Description: Anchor/screw for bone fixation, absorbable, metallic (implantable) |
| C7566 | Fuse finger joints w/grafts | Description: Arthrodesis, interphalangeal joints, with or without internal fixation, with autografts (includes obtaining grafts) |
| C7567 | Bronch/needle bx(s) w/ nav | Description: Bronchoscopy, rigid or flexible, including fluoroscopic guidance when performed, with transbronchial needle aspiration biopsy(s), trachea, main stem and/or lobar bronchus(i), with computer-assisted image-guided naviagation |
| C7568 | Cor angio w/flow resrv | Description: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress |
| C7569 | Ptca w/ ivus or oct | Description: Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report |
| C7570 | Cor angio w/ffr & 3d map | Description: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention (list separately in addition to code for primary procedure) |
| C7571 | Pcta w/ cor lithotrip | Description: Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with percutaneous transluminal coronary lithotripsy |
| C8925 | 2d tee w or w/o fol w/con,in | Description: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report |
| C8926 | Tee w or w/o fol w/cont,cong | Description: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report |
| C8927 | Tee w or w/o fol w/cont, mon | Description: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis |
| C9144 | Inj, bupivacaine (posimir) | Description: Injection, bupivacaine (posimir), 1 mg |
| C9176 | Dom nonheu tc99m add-on/dose | Description: Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose |
| C9307 | Inj linvoseltamab-gcpt 1 mg | Description: Injection, linvoseltamab-gcpt, 1 mg |
| C9308 | Inj, carboplatin (avyxa) | Description: Injection, carboplatin (avyxa), 1 mg |
| C9363 | Integra meshed bil wound mat | Description: Skin substitute, integra meshed bilayer wound matrix, per square centimeter |
| C9602 | Perc d-e cor stent ather s | Description: Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch |
| C9604 | Perc d-e cor revasc t cabg s | Description: Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel |
| C9607 | Perc d-e cor revasc chro sin | Description: Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel |
| C9760 | Non-blind interatrial shunt | Description: Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study |
| C9779 | Esd endoscopy or colonoscopy | Description: Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed |
| C9780 | Insert cv cath inf & sup app | Description: Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance |
| C9782 | Blind myocar trpl bon marrow | Description: Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study |
| C9783 | Blind cor sinus reducer impl | Description: Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study |
| C9785 | Endo outlet restrict w/tube | Description: Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components |
| C9792 | Blind/nonblind trans atrial | Description: Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study) |
| C9810 | Cold therapy non-opioid dev | Description: Water circulating motorized cold therapy device (e.g., iceman) including all system components (e.g. pads, console, disposable parts), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) |
| C9811 | Elec amb pmp nonopioid dev | Description: Electronic ambulatory infusion pump (e.g. sapphire pump), including all pump components, including disposable components , non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) |
| C9812 | Echgnc nv ndls nonopioid dev | Description: Echogenic nerve block needles (e.g. sonoplex, sonoblock, sonotap), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) |
| C9813 | Prf infs cth nonopioid dev | Description: Perforated continuous infusion catheter set (e.g. infiltralong), including all components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) |
| C9814 | Echognc cathr nonopioid dev | Description: Continuous anesthesia echogenic conduction catheter set (e.g. sonolong), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) |
| C9815 | Peristlc pmp nonopioid dev | Description: Linear peristaltic pain management infusion pump (e.g. cadd-solis ambulatory infusion pump), and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) |
| C9816 | Pmp prs reusbl nonopioid dev | Description: Rotary peristaltic infusion pump (e.g., reusable ambit pump) including all disposable system components, reusable non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) |
| C9817 | Crypnm cmprs nonopioid dev | Description: Electronic cryo-pneumatic compression, pain management system (e.g. game ready grpro 2.1 system), including control unit, anatomically correct wrap(s), and other system component(s), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023) |
| C9901 | Endo defect closure gi tract | Description: Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components |
| G0136 | Adm of pa/n assess 5-15 m | Description: Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
| G0412 | Open tx iliac spine uni/bil | Description: Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed |
| G0413 | Pelvic ring fracture uni/bil | Description: Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum) |
| G0414 | Pelvic ring fx treat int fix | Description: Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami) |
| G0415 | Open tx post pelvic fxcture | Description: Open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum) |
| G0438 | Ppps, initial visit | Description: Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
| G0568 | Int psych care mng, 1 cal mo | Description: Initial psychiatric collaborative care management, in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional, initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan, review by the psychiatric consultant with modifications of the plan if recommended, entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant, and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies (list separately in addition to the advanced primary care management code) |
| G0569 | Subs psych care mng, subs mo | Description: Subsequent psychiatric collaborative care management, in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment (list separately in addition to advanced primary care management code) |
| G0570 | Care manage serv, pr cal mo | Description: Care management services for behavioral health conditions, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales, behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes, facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation, and continuity of care with a designated member of the care team (list separately in addition to advanced primary care management code) |
| G0571 | Intraop nerve cryoablation | Description: Intraoperative nerve(s) cryoablation for post-surgical pain relief (list separately in addition to code for primary service) |
| G0660 | Team remote e/m new pt 10 mn | Description: Team remote e/m new pt 10mins |
| G0661 | Team remote e/m new pt 20 mn | Description: Team remote e/m new pt 20mins |
| G0662 | Team remote e/m new pt 30 mn | Description: Team remote e/m new pt 30 mins |
| G0663 | Team remote e/m new pt 45 mn | Description: Team remote e/m new pt 45mins |
| G0664 | Team remote e/m new pt 60 mn | Description: Team remote e/m new pt 60mins |
| G0665 | Team remote e/m est pt 10 mn | Description: Team remote e/m est. pt 10mins |
| G0666 | Team remote e/m est pt 15 mn | Description: Team remote e/m est. pt 15mins |
| G0667 | Team remote e/m est pt 25 mn | Description: Team remote e/m est. pt 25mins |
| G0668 | Team remote e/m est pt 40 mn | Description: Team remote e/m est. pt 40mins |
| G2076 | Intake act w/med exam | Description: Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a standardized, evidence-based assessment, and that includes the patient's goals and mutually agreed-upon actions for the patient to meet those goals, including harm reduction interventions; the patient's needs and goals in the areas of education, vocational training, and employment; and the medical and psychiatric, psychosocial, economic, legal, housing, physical activity and/or nutrition needs and other recovery support services that a patient needs and wishes to pursue, conducted by an appropriately licensed/credentialed personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code |
| G2077 | Periodic assessment | Description: Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical, nutrition and psychiatric treatment needs and goals; may be informed by administration of a standardized, evidence-based assessment, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code |
| G8430 | Doc med rsn no medrec | Description: Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) |
| G9414 | 1dose menig vac btwn 10 & 13 | Description: Patient had one dose of meningococcal vaccine (serogroups a, c, w, y or a, c, w, y, b) on or between the patient's 10th and 13th birthdays |
| G9415 | No 1dose meni vac btwn 10&13 | Description: Patient did not have one dose of meningococcal vaccine (serogroups a, c, w, y or a, c, w, y, b), on or between the patient's 10th and 13th birthdays |
| G9788 | Most rct bp </= 130/80 | Description: Most recent bp is less than or equal to 130/80 mm hg |
| G9790 | Most rct bp >/= 130/80 | Description: Most recent bp is greater than 130/80 mm hg, or blood pressure not documented |
| G9796 | Pt currently on statin | Description: Patient is currently on a high intensity statin therapy |
| G9797 | Pt not currently on statin | Description: Patient is not on a high intensity statin therapy |
| G9832 | Br ca stg = 1 t stg = t1c | Description: Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis = t1c |
| G9871 | Bhv couns dm prev, onln 60 m | Description: Behavioral counseling for diabetes prevention, online, 60 minutes |
| J0013 | Esketamine, nasal spray | Description: Esketamine, nasal spray, 1 mg |
| J0162 | Inj epinephrine (fresenius) | Description: Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg |
| J0209 | Inj, sod thiosulfate (hope) | Description: Injection, sodium thiosulfate (hope), 100 mg |
| J0248 | Inj, remdesivir, 1 mg | Description: Injection, remdesivir, 1 mg |
| J0654 | Inj, liothyronine, 1 mcg | Description: Injection, liothyronine, 1 mcg |
| J0720 | Chloramphenicol sodium injec | Description: Injection, chloramphenicol sodium succinate, up to 1 gm |
| J0759 | Inj, clevidipine, 1 mg | Description: Injection, clevidipine butyrate, 1 mg |
| J1073 | Testosterone pellet 75 mg | Description: Testosterone pellet, implant, 75 mg |
| J1736 | Inj meloxicam (delova) 1mg | Description: Injection, meloxicam (delova), 1 mg |
| J1737 | Inj meloxicam (azurity) 1mg | Description: Injection, meloxicam (azurity), 1 mg |
| J1837 | Inj, posaconazole, 1 mg | Description: Injection, posaconazole, 1 mg |
| J2515 | Pentobarbital sodium inj | Description: Injection, pentobarbital sodium, per 50 mg |
| J2516 | Inj, pentamidine isethionate | Description: Injection, pentamidine isethionate, 1 mg |
| J2596 | Vasopressin (long grove) 1 u | Description: Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit |
| J2711 | Inj neostigmin/glycopyrrolat | Description: Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg |
| J3291 | Tranexamic acid in sod chlor | Description: Injection, tranexamic acid in sodium chloride, 5 mg |
| J3376 | Inj vancomycin (hikma) 10mg | Description: Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg |
| J3379 | Inj, valproate sod, 5 mg | Description: Injection, valproate sodium, 5 mg |
| J3387 | Inj elivaldogene autotemecel | Description: Injection, elivaldogene autotemcel, per treatment |
| J3389 | Topi adm prad zami per treat | Description: Topical administration, prademagene zamikeracel, per treatment |
| J3485 | Zidovudine | Description: Injection, zidovudine, 10 mg |
| J7191 | Factor viii (porcine) | Description: Factor viii (antihemophilic factor (porcine)), per i.u. |
| J7299 | Intraut copp cont (miudella) | Description: Intrauterine copper contraceptive (miudella) |
| J7322 | Hyaluronan, hymo or hymo one | Description: Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg |
| J7528 | Mycophen mofetil for susp | Description: Mycophenolate mofetil, for suspension, oral, 100 mg |
| J9030 | Bcg live intravesical 1mg | Description: Bcg live intravesical instillation, 1 mg |
| J9184 | Inj gemcitabin (avyxa) 200mg | Description: Injection, gemcitabine hydrochloride (avyxa), 200 mg |
| J9256 | Inj, nipocalimab-aahu, 3 mg | Description: Injection, nipocalimab-aahu, 3 mg |
| J9282 | Mitomycin intravesical inst | Description: Mitomycin, intravesical instillation, 1 mg |
| J9326 | Telisotuzumab vedotin-tllv | Description: Injection, telisotuzumab vedotin-tllv, 1 mg |
| M0010 | Eom meos payment | Description: Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services |
| M1174 | Pt w/ 2 hzv 10/2017 - mp | Description: Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period |
| M1176 | No 2 hzv 10/2017-meas pd | Description: Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period |
| M1426 | Telehealth enc | Description: Encounters conducted via telehealth |
| M1427 | Doc med rsn bone scn | Description: Documentation of medical reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, other medical reasons) |
| M1428 | Bilateral absence of eyes | Description: Patients who have bilateral absence of eyes any time during the patient's history through the end of the measurement period |
| M1429 | Retinopathy in od, os, ou | Description: Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented |
| M1430 | Ret exm ou no retinopthy doc | Description: Retinal exam finding without evidence of retinopathy in both eyes with severity level documented (in measurement year or in the prior year) |
| M1431 | Telehealth enc | Description: Encounters conducted via telehealth |
| M1432 | Telehealth enc | Description: Encounters conducted via telehealth |
| M1433 | Oral chemo wthn 30 days enc | Description: Patient on oral chemotherapy on or within 30 days before denominator eligible encounter |
| M1434 | Orl chemo wthn 30 d post enc | Description: Patient on oral chemotherapy on or within 30 days after denominator eligible encounter |
| M1435 | Oral chemo in perf pd | Description: Patient on oral chemotherapy during the performance period |
| M1436 | Telehealth enc | Description: Encounters conducted via telehealth |
| M1437 | Telehealth enc | Description: Encounters conducted via telehealth |
| M1438 | Lst knwn well <=210 min | Description: Time last known well to hospital arrival less than or equal to 3.5 hours (<= 210 minutes) |
| M1439 | Sig ocu cond imp surg out | Description: Significant ocular conditions that impact the visual outcome of surgery |
| M1440 | Telehealth enc | Description: Encounters conducted via telehealth |
| M1441 | Init dx slp apn = 1st enc | Description: Encounter corresponds to initial diagnosis of sleep apnea or first contact with sleep apnea diagnosed patient |
| M1442 | Telehealth enc | Description: Encounters conducted via telehealth |
| M1443 | Telehealth enc | Description: Encounters conducted via telehealth |
| M1444 | Del < 39 weeks gest | Description: Delivery at < 39 weeks of gestation |
| M1445 | Pp care visit by 12 weeks | Description: Postpartum care visit before or at 12 weeks of giving birth |
| M1446 | Pt died bef end meas pd | Description: Patients who died any time prior to the end of the measure assessment period |
| M1447 | Pt dx bd bef end meas pd | Description: Patients with an active diagnosis of bipolar disorder any time prior to the end of the measure assessment period |
| M1448 | Pt dx pd bef end meas pd | Description: Patients with an active diagnosis of personality disorder any time prior to the end of the measure assessment period |
| M1449 | Pt dx scz/pys bef end msr pd | Description: Patients with an active diagnosis of schizophrenia or psychotic disorder any time prior to the end of the measure assessment period |
| M1450 | Pt hos/pal care dur id/pf pd | Description: Patients who received hospice or palliative care service any time during denominator identification period or the measure assessment period |
| M1451 | Pt dx ppd dur id/pf pd | Description: Patients with an active diagnosis of pervasive developmental disorder any time prior to the end of the measure assessment period |
| M1452 | Pt dx dementia ever | Description: Patient ever had a diagnosis of dementia |
| M1453 | Preop vis acu > 20/40 | Description: Patients with a pre-operative visual acuity better than 20/40 |
| M1454 | New cied | Description: New cied |
| M1455 | Rep/rev cied | Description: Replaced or revised cied |
| M1456 | Pt had htx | Description: Patient had a heart transplant |
| M1457 | Dx asth dur crnt/prv perf pd | Description: Patient had a diagnosis of asthma with any contact during the current or prior performance period or had asthma present on an active problem list any time during the performance period |
| M1458 | Pt died bef end meas pd | Description: Patient died prior to the end of the performance period |
| M1459 | Pt hosp/pal care dur perf pd | Description: Patient was in hospice or receiving palliative care services at any time during the performance period |
| M1460 | Dx copd, cf, or arf | Description: Diagnosis for chronic obstructive pulmonary disease, emphysema, cystic fibrosis, or acute respiratory failure |
| M1461 | Pt dx chron hepc | Description: Patient diagnosis for chronic hepatitis c |
| M1462 | Pt clin ind hd image | Description: Patients with clinical indications for imaging of the head |
| M1463 | 2 f/u wthn 180 day rx atmp | Description: Documentation of at least two attempts to follow up with patient within 180 days of treatment |
| M1464 | No record of f/u by 180 days | Description: No documentation of at least two attempts to follow up with patient within 180 days of treatment |
| M1465 | F/u > 180 days after rx | Description: Patient follow up more than 180 days after treatment |
| M1466 | Pt disc/lam proc same day | Description: Patient had a lumbar fusion on the same date as the discectomy/laminectomy procedure |
| M1467 | Pt dx lynch syn | Description: Patients with an existing diagnosis of lynch syndrome |
| M1468 | Hep b vaccine received | Description: Patient received recommended doses of hepatitis b vaccination based on age |
| M1469 | Hx of hep b, or pos bld test | Description: Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period |
| M1470 | Hep b vac not rec'd med rsn | Description: Documentation of medical reason(s) for not administering hepatitis b vaccine (e.g., prior anaphylaxis due to the hepatitis b vaccine) |
| M1471 | Ffs hep b not covered | Description: Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules |
| M1472 | Hep b vaccine not received | Description: Patient did not receive recommended doses of hepatitis b vaccination based on age |
| M1473 | Pt func cap not allow impr | Description: Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools, such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders |
| M1474 | Pt dx dementia | Description: Patients with diagnosis of dementia |
| M1475 | Pt dx huntington | Description: Patients with diagnosis of huntington's disease |
| M1476 | Pt dx cog imp or ad | Description: Patients with diagnosis of cognitive impairment or alzheimer's disease |
| M1477 | Dx delirium | Description: Diagnosis of delirium |
| M1478 | Psychoactive sub abuse | Description: Psychoactive substance abuse |
| M1479 | Pt func cap not allow impr | Description: Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders |
| M1480 | Pt func cap not allow impr | Description: Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders |
| M1481 | Pt in hosp/pal care who died | Description: Patients receiving hospice or palliative care or who died during the measurement period |
| M1482 | Pos quan hep c or qual rna | Description: Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period |
| M1483 | Neg quan hep c or qual rna | Description: Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period |
| M1484 | No rpt hcv rna perf med rsn | Description: Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis) |
| M1485 | Neg viro resp hep c/qual rna | Description: Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period |
| M1486 | Pt admitted to snf dur eval | Description: Patients admitted to a skilled nursing facility (snf) during the period of evaluation |
| M1487 | Pt adm to hospice dur eval | Description: Patients in hospice in the year before or during the period of evaluation |
| M1488 | Dx dementia in msr timeframe | Description: Patients with a diagnosis for dementia in the year before or during the period of evaluation |
| M1489 | Pt status doc | Description: Patient status documented |
| M1490 | Pt status not doc | Description: Patient status not documented |
| M1491 | Rec'd esrd mcp dur perf pd | Description: Receiving esrd mcp dialysis services by the provider during the performance period |
| M1492 | No reported fall | Description: Patients who did not report a fall |
| M1493 | No fall doc med rsn | Description: Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy) |
| M1494 | Fall rep since last visit | Description: Patients that reported a fall since the last visit |
| M1495 | Fall w/ poc, no fall | Description: Patients that reported a fall occurred who had a plan of care for falls documented or patients that did not report a fall |
| M1496 | No doc of fall or poc | Description: Patients that had a fall who did not have a plan of care for falls documented or do not have documentation of being assessed for falls |
| M1497 | No doc fall med rsn | Description: Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy) |
| M1498 | Diagnostic radiology mvp | Description: Diagnostic radiology mips value pathway |
| M1499 | Interventional radiology mvp | Description: Interventional radiology mips value pathway |
| M1500 | Neuropsychology mvp | Description: Neuropsychology mips value pathway |
| M1501 | Pathology mvp | Description: Pathology mips value pathway |
| M1502 | Podiatry mvp | Description: Podiatry mips value pathway |
| M1503 | Vascular surgery mvp | Description: Vascular surgery mips value pathway |
| Q2057 | Afamitresgene autoleucel | Description: Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose |
| Q2058 | Obecbtge autol up to 400 mil | Description: Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion |
| Q4101 | Apligraf | Description: Apligraf, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4102 | Oasis wound matrix | Description: Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4103 | Oasis burn matrix | Description: Oasis burn matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4104 | Integra bmwd | Description: Integra bilayer matrix wound dressing (bmwd), per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4105 | Integra drt or omnigraft | Description: Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4107 | Graftjacket | Description: Graftjacket, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4108 | Integra matrix | Description: Integra matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4110 | Primatrix | Description: Primatrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4111 | Gammagraft | Description: Gammagraft, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4112 | Cymetra injectable | Description: Cymetra, injectable, 1 cc |
| Q4113 | Graftjacket xpress | Description: Graftjacket xpress, injectable, 1 cc |
| Q4114 | Integra flowable wound matri | Description: Integra flowable wound matrix, injectable, 1 cc |
| Q4115 | Alloskin | Description: Alloskin, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4116 | Alloderm | Description: Alloderm, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4117 | Hyalomatrix | Description: Hyalomatrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4118 | Matristem micromatrix | Description: Matristem micromatrix, 1 mg |
| Q4121 | Theraskin | Description: Theraskin, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4122 | Dermacell, awm, porous sq cm | Description: Dermacell, dermacell awm or dermacell awm porous, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4123 | Alloskin | Description: Alloskin rt, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4124 | Oasis tri-layer wound matrix | Description: Oasis ultra tri-layer wound matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4125 | Arthroflex | Description: Arthroflex, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4126 | Memoderm/derma/tranz/integup | Description: Memoderm, dermaspan, tranzgraft or integuply, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4127 | Talymed | Description: Talymed, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4128 | Flexhd/allopatchhd/sq cm | Description: Flex hd, or allopatch hd, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4130 | Strattice tm | Description: Strattice tm, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4132 | Grafix core, grafixpl core | Description: Grafix core and grafixpl core, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4133 | Grafix stravix prime pl sqcm | Description: Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4134 | Hmatrix | Description: Hmatrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4135 | Mediskin | Description: Mediskin, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4136 | Ezderm | Description: Ez-derm, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4137 | Amnioexcel biodexcel 1sq cm | Description: Amnioexcel, amnioexcel plus or biodexcel, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4138 | Biodfence dryflex, 1cm | Description: Biodfence dryflex, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4139 | Amnio or biodmatrix, inj 1cc | Description: Amniomatrix or biodmatrix, injectable, 1 cc |
| Q4140 | Biodfence 1cm | Description: Biodfence, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4141 | Alloskin ac, 1 cm | Description: Alloskin ac, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4142 | Xcm biologic tiss matrix 1cm | Description: Xcm biologic tissue matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4143 | Repriza, 1cm | Description: Repriza, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4145 | Epifix, inj, 1mg | Description: Epifix, injectable, 1 mg |
| Q4146 | Tensix, 1cm | Description: Tensix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4147 | Architect ecm px fx 1 sq cm | Description: Architect, architect px, or architect fx, extracellular matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4148 | Neox neox rt or clarix cord | Description: Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4149 | Excellagen, 0.1 cc | Description: Excellagen, 0.1 cc |
| Q4150 | Allowrap ds or dry 1 sq cm | Description: Allowrap ds or dry, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4151 | Amnioband, guardian 1 sq cm | Description: Amnioband or guardian, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4152 | Dermapure 1 square cm | Description: Dermapure, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4153 | Dermavest, plurivest sq cm | Description: Dermavest and plurivest, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4154 | Biovance 1 square cm | Description: Biovance, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4155 | Neoxflo or clarixflo 1 mg | Description: Neoxflo or clarixflo, 1 mg |
| Q4156 | Neox 100 or clarix 100 | Description: Neox 100 or clarix 100, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4157 | Revitalon 1 square cm | Description: Revitalon, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4158 | Kerecis omega3, per sq cm | Description: Kerecis omega3, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4159 | Affinity1 square cm | Description: Affinity, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4160 | Nushield 1 square cm | Description: Nushield, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4161 | Bio-connekt per square cm | Description: Bio-connekt wound matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4162 | Wndex flw, bioskn flw, 0.5cc | Description: Woundex flow, bioskin flow, 0.5 cc |
| Q4163 | Woundex, bioskin, per sq cm | Description: Woundex, bioskin, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4164 | Helicoll, per square cm | Description: Helicoll, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4165 | Keramatrix, kerasorb sq cm | Description: Keramatrix or kerasorb, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4166 | Cytal, per square centimeter | Description: Cytal, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4167 | Truskin, per sq centimeter | Description: Truskin, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4168 | Amnioband, 1 mg | Description: Amnioband, 1 mg |
| Q4169 | Artacent wound, per sq cm | Description: Artacent wound, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4170 | Cygnus, per sq cm | Description: Cygnus, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4171 | Interfyl, 1 mg | Description: Interfyl, 1 mg |
| Q4173 | Palingen or palingen xplus | Description: Palingen or palingen xplus, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4174 | Palingen or promatrx | Description: Palingen or promatrx, 0.36 mg per 0.25 cc |
| Q4175 | Miroderm | Description: Miroderm, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4176 | Neopatch or therion, 1 sq cm | Description: Neopatch or therion, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4177 | Floweramnioflo, 0.1 cc | Description: Floweramnioflo, 0.1 cc |
| Q4178 | Floweramniopatch, per sq cm | Description: Floweramniopatch, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4179 | Flowerderm, per sq cm | Description: Flowerderm, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4180 | Revita, per sq cm | Description: Revita, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4181 | Amnio wound, per square cm | Description: Amnio wound, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4182 | Transcyte, per sq centimeter | Description: Transcyte, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4183 | Surgigraft, 1 sq cm | Description: Surgigraft, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4184 | Cellesta or duo per sq cm | Description: Cellesta or cellesta duo, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4185 | Cellesta flowab amnion 0.5cc | Description: Cellesta flowable amnion (25 mg per cc); per 0.5 cc |
| Q4186 | Epifix 1 sq cm | Description: Epifix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4187 | Epicord 1 sq cm | Description: Epicord, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4188 | Amnioarmor 1 sq cm | Description: Amnioarmor, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4189 | Artacent ac, 1 mg | Description: Artacent ac, 1 mg |
| Q4190 | Artacent ac 1 sq cm | Description: Artacent ac, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4191 | Restorigin 1 sq cm | Description: Restorigin, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4192 | Restorigin, 1 cc | Description: Restorigin, 1 cc |
| Q4193 | Coll-e-derm 1 sq cm | Description: Coll-e-derm, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4194 | Novachor 1 sq cm | Description: Novachor, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4195 | Puraply 1 sq cm | Description: Puraply, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4196 | Puraply am 1 sq cm | Description: Puraply am, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4197 | Puraply xt 1 sq cm | Description: Puraply xt, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4198 | Genesis amnio membrane 1sqcm | Description: Genesis amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4199 | Cygnus matrix, per sq cm | Description: Cygnus matrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4200 | Skin te 1 sq cm | Description: Skin te, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4201 | Matrion 1 sq cm | Description: Matrion, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4202 | Keroxx (2.5g/cc), 1cc | Description: Keroxx (2.5g/cc), 1cc |
| Q4203 | Derma-gide, 1 sq cm | Description: Derma-gide, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4204 | Xwrap 1 sq cm | Description: Xwrap, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4205 | Membrane graft or wrap sq cm | Description: Membrane graft or membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4206 | Fluid flow or fluid gf 1 cc | Description: Fluid flow or fluid gf, 1 cc |
| Q4208 | Novafix per sq cm | Description: Novafix, per square cenitmeter (add-on, list separately in addition to primary procedure) |
| Q4209 | Surgraft per sq cm | Description: Surgraft, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4211 | Amnion bio or axobio sq cm | Description: Amnion bio or axobiomembrane, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4212 | Allogen, per cc | Description: Allogen, per cc |
| Q4213 | Ascent, 0.5 mg | Description: Ascent, 0.5 mg |
| Q4214 | Cellesta cord per sq cm | Description: Cellesta cord, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4215 | Axolotl ambient, cryo 0.1 mg | Description: Axolotl ambient or axolotl cryo, 0.1 mg |
| Q4216 | Artacent cord per sq cm | Description: Artacent cord, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4217 | Woundfix biowound plus xplus | Description: Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4218 | Surgicord per sq cm | Description: Surgicord, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4219 | Surgigraft dual per sq cm | Description: Surgigraft-dual, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4220 | Bellacell hd, surederm sq cm | Description: Bellacell hd or surederm, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4221 | Amniowrap2 per sq cm | Description: Amniowrap2, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4222 | Progenamatrix, per sq cm | Description: Progenamatrix, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4224 | Hhf10-p per sq cm | Description: Human health factor 10 amniotic patch (hhf10-p), per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4225 | Amnio or derma tl, per sq cm | Description: Amniobind or dermabind tl, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4227 | Amniocore per sq cm | Description: Amniocore, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4229 | Cogenex amnio memb per sq cm | Description: Cogenex amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4230 | Cogenex flow amnion 0.5 cc | Description: Cogenex flowable amnion, per 0.5 cc |
| Q4232 | Corplex, per sq cm | Description: Corplex, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4233 | Surfactor /nudyn per 0.5 cc | Description: Surfactor or nudyn, per 0.5 cc |
| Q4234 | Xcellerate, per sq cm | Description: Xcellerate, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4235 | Amniorepair or altiply sq cm | Description: Amniorepair or altiply, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4236 | Carepatch per sq cm | Description: Carepatch, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4237 | Cryo-cord, per sq cm | Description: Cryo-cord, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4238 | Derm-maxx, per sq cm | Description: Derm-maxx, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4239 | Amnio-maxx or lite per sq cm | Description: Amnio-maxx or amnio-maxx lite, per square centimeter (add-on, list separately in addition to primary procedure) |
| Q4240 | Corecyte topical only 0.5 cc | Description: Corecyte, for topical use only, per 0.5 cc |
| Q4241 | Polycyte, topical only 0.5cc | Description: Polycyte, for topical use only, per 0.5 cc |
| Q4242 | Amniocyte plus, per 0.5 cc | Description: Amniocyte plus, per 0.5 cc |
| Q4245 | Amniotext, per cc | Description: Amniotext, per cc |
| Q4246 | Coretext or protext, per cc | Description: Coretext or protext, per cc |
| Q4247 | Amniotext patch, per sq cm | Description: Amniotext patch, per square centimeter (add-on, list separately in addition to primary procedure) |